Cite
HARVARD Citation
Wang, H. et al. (2022). Chinese breast cancer patients with CYP2D6*10 mutant genotypes have a better prognosis with toremifene than with tamoxifen. Asia-Pacific journal of clinical oncology. 18 (2), pp. e148-e153. [Online].